Takeda Pharmaceuticals
About
Takeda Pharmaceuticals is the Japan-based global biopharmaceutical company whose global hub and research center are in Cambridge. Its R&D organization focuses on unlocking scientific innovation and turning it into transformative therapies, concentrating on a set of core therapeutic areas and making targeted investments to push new medicines forward. Its research covers hematologic cancers, bleeding and rare blood disorders, neuroscience and other areas, with an emphasis on advancing science where patient needs are greatest.
Recent results from that pipeline include U.S. approvals for MIMRYLO, a hepcidin mimetic for polycythemia vera, and ORZEYFUL, the first medicine to treat the underlying cause of narcolepsy type 1. The company also studies elritercept for anemia in myelodysplastic syndromes and myelofibrosis. Takeda, founded in Osaka in 1781, has built a large Massachusetts workforce through acquisitions such as Millennium Pharmaceuticals and Shire, and it is now the largest life sciences employer in the state.
What to Know
- Takeda’s oncology work is led by a dedicated Oncology Therapeutic Area Unit.
- The company brought more than 25 presentations to the 2025 American Society of Hematology annual meeting.
- It partners with The Greater Boston Food Bank on community health.
- This listing is part of the Central Square Business Improvement District.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.